Sign In

Mary Wheeler

Founder, Managing Director, GP at BioRock Ventures

Mary Wheeler is the Founding Managing Director of BioRock Ventures, a venture capital firm based in the San Francisco Bay Area that focuses on investing in seed-stage biopharma startups developing novel FDA-regulated therapeutic drugs. With over two decades of experience in the biotechnology and pharmaceutical sectors, she has held various leadership roles, including negotiating mergers and acquisitions and leading business development efforts at major companies such as Johnson & Johnson and Forest Laboratories (now part of AbbVie) in New York City.13

Wheeler's educational background includes a PhD in Cognitive Neuroscience from Princeton University, an MBA from the MIT Sloan School of Management, and a BA from Yale University. She is also a Kauffman Fellow, which highlights her expertise in venture capital and entrepreneurship.123 In addition to her role at BioRock, she has served as a consultant and advisor to numerous early-stage ventures globally and has a strong track record in venture investing, having contributed to the formation of companies that achieved IPO exits valued over $1 billion.134

Beyond her professional pursuits, Wheeler enjoys sports such as snowboarding and horseback riding.1

Highlights

Mar 28 · youtube.com
Mary Wheeler Bio-Rock Ventures - YouTube
Mary Wheeler Bio-Rock Ventures - YouTube
May 4 · mebfaber.com
Mary Wheeler, BioRock Ventures, “2019…There Were 20 $1B IPOs ...

Related Questions

What are some of the most successful investments made by BioRock Ventures?
How did Mary Wheeler transition from pharmaceutical companies to venture capital?
What unique strategies does BioRock Ventures use in their investments?
Can you provide examples of startups that BioRock Ventures has funded?
What inspired Mary Wheeler to start BioRock Ventures?
Mary Wheeler
Mary Wheeler, photo 1
Mary Wheeler, photo 2
Add to my network

Experience

Founding Managing Director at BioRock Ventures (July 2019 - Present)
Investor AngelList Syndicate, Therapeutics at AngelList (June 2017 - January 2021), Chief Business Officer/Advisor/Consultant to startups and growing companies (September 2014 - January 2021), Mentor at StartX, IndieBio, ELabNYC, Other Accelerators (September 2014 - June 2020), Kauffman Fellow, Class 18 at Kauffman Fellows Program (July 2013 - June 2015), Innovation Center, New Venture Partnerships and Transactions at Johnson & Johnson (January 2013 - September 2014), M&A, Licensing and Strategic Planning at Forest Laboratories (March 2008 - December 2012), Head of Business Development & Licensing, Founding Team at Ariston Pharmaceuticals (2004 - February 2008)

Education

Venture Capital Investing, Entrepreneur Mentorship - Kauffman Fellows (2013 - 2015), Bachelor of Arts - BA - Yale University, MBA, New Product and Venture Development Track - Entrepreneurship - MIT Sloan School of Management, PhD, Cognitive Neuroscience - Princeton University

Location

San Francisco Bay Area